Diligence memo · auto-generated · as of July 2, 2026

Aeneas Parent Corp.

Aeneas Parent Corp. looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Aeneas Parent Corp. operates in Other Health Care, based in NEW YORK.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Aeneas Parent Corp. has raised $298M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).

Largest single filing: $253M on 2015-12-18.

Most recent recorded round closed around 2016-01-07.

Valuation (modeled)modeled

Provath models Aeneas Parent Corp. at approximately $644M (range $149M–$1.4B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.17× the median modeled value of Series D+ Other Health Care companies in 2016–2018 (7 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 0 months.

Last raise 10.5 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.6× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 99% of Other Health Care peers (5377 compared).

Modeled value ranks above 95% of those peers.

Closest niche peers: BNVC Group Holdings, Inc., Endologix Inc /De/, SYFS Intermediate Holdings, LLC, Allied Integral United, Inc., OneOncology Parent Holdings, LLC.

Peoplefiled

9 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.